BiotechTube
Home/AstraZeneca/Susan Galbraith
SG

Susan Galbraith

Executive Vice President, Oncology R&D

AstraZeneca

Therapeutic Areas

OncologyCardiovascular/Renal/MetabolicRespiratory & ImmunologyRare DiseaseVaccines & Immune Therapies

AstraZeneca Pipeline

DrugIndicationPhase
Datopotamab deruxtecanNon-small cell lung cancer (NSCLC)Phase III
Volrustomig1L Non-small cell lung cancerPhase III
CamizestrantER+ Breast CancerPhase III
BaxdrostatResistant HypertensionPhase III
AcoramidisATTR CardiomyopathyRegulatory Review
TozorakimabCOPDPhase III
EplontersenATTR PolyneuropathyPhase III / Marketed
AZD7789Advanced Solid TumorsPhase I/II

Leadership Team at AstraZeneca

PS
Pascal Soriot
Executive Director and Chief Executive Officer
AS
Aradhana Sarin
Chief Financial Officer
SM
Sir Mene Pangalos
Executive Vice President, BioPharmaceuticals R&D
BD
Brigitte de Lima
Senior Vice President, Chief Data & AI Officer
View full AstraZeneca profile